[go: up one dir, main page]

SE466451B - Estrar av (6r,7r)-3-karbomoyloximetyl-7-/ (z)-2-(fur-2-yl)-2-metoxi-iminoacetamido /cef-3-em-4-karboxylsyra - Google Patents

Estrar av (6r,7r)-3-karbomoyloximetyl-7-/ (z)-2-(fur-2-yl)-2-metoxi-iminoacetamido /cef-3-em-4-karboxylsyra

Info

Publication number
SE466451B
SE466451B SE8500011A SE8500011A SE466451B SE 466451 B SE466451 B SE 466451B SE 8500011 A SE8500011 A SE 8500011A SE 8500011 A SE8500011 A SE 8500011A SE 466451 B SE466451 B SE 466451B
Authority
SE
Sweden
Prior art keywords
compound
formula
solution
cef
acid
Prior art date
Application number
SE8500011A
Other languages
English (en)
Swedish (sv)
Inventor
G G Weingarten
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE466451B publication Critical patent/SE466451B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C07C59/315—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8500011A 1984-01-03 1985-01-02 Estrar av (6r,7r)-3-karbomoyloximetyl-7-/ (z)-2-(fur-2-yl)-2-metoxi-iminoacetamido /cef-3-em-4-karboxylsyra SE466451B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848400024A GB8400024D0 (en) 1984-01-03 1984-01-03 Cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
SE466451B true SE466451B (sv) 1992-02-17

Family

ID=10554497

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8500011A SE466451B (sv) 1984-01-03 1985-01-02 Estrar av (6r,7r)-3-karbomoyloximetyl-7-/ (z)-2-(fur-2-yl)-2-metoxi-iminoacetamido /cef-3-em-4-karboxylsyra
SE8500011D SE8500011L (sv) 1984-01-03 1985-01-02 Cefalosporinantibiotika

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8500011D SE8500011L (sv) 1984-01-03 1985-01-02 Cefalosporinantibiotika

Country Status (28)

Country Link
US (1) US4602012A (nl)
JP (1) JPH0791305B2 (nl)
KR (1) KR920001770B1 (nl)
AT (1) AT392279B (nl)
AU (1) AU578441B2 (nl)
BE (1) BE901436A (nl)
CA (1) CA1265512A (nl)
CH (1) CH666274A5 (nl)
DE (1) DE3500090A1 (nl)
DK (1) DK1585A (nl)
ES (2) ES8703884A1 (nl)
FI (1) FI83082C (nl)
FR (1) FR2557571B1 (nl)
GB (2) GB8400024D0 (nl)
GR (1) GR850007B (nl)
HK (1) HK105890A (nl)
HU (1) HU193076B (nl)
IL (1) IL73989A (nl)
IT (1) IT1178349B (nl)
LU (1) LU85719A1 (nl)
NL (1) NL8403974A (nl)
NO (1) NO165400C (nl)
NZ (1) NZ210725A (nl)
PH (1) PH22630A (nl)
PT (1) PT79787B (nl)
SE (2) SE466451B (nl)
SG (1) SG81390G (nl)
ZA (1) ZA8545B (nl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
GB8810395D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810392D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810393D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810396D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810394D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
EP0508943B1 (de) * 1991-03-11 1994-12-14 Säurefabrik Schweizerhall Verfahren zur Herstellung von halogenierten Carbonsäureestern
DK0504107T3 (da) * 1991-03-11 1995-02-13 Schweizerhall Saeurefab Fremgangsmåde til fremstilling af chlorerede carboxylsyreestere
GB9405856D0 (en) * 1994-03-24 1994-05-11 Smithkline Beecham Plc Pharmaceutical formulation
JP2001131071A (ja) * 1999-10-29 2001-05-15 Meiji Seika Kaisha Ltd 非晶質および非晶質を含有する医薬組成物
DE60221787T2 (de) * 2002-03-04 2008-06-05 Orbus Pharma Inc. Zusammensetzungen mit schneller Freisetzung enthaltend Cefuroxime Axetil
WO2008155615A2 (en) * 2007-06-18 2008-12-24 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of cephalosporin antibiotic

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1453049A (en) * 1973-08-21 1976-10-20 Glaxo Lab Ltd Cephalosporing antibiotics
GB1426717A (en) * 1972-03-13 1976-03-03 Astra Laekemedel Ab Penicillins
GB1425933A (en) * 1972-03-13 1976-02-25 Astra Laekemedel Ab Cephalosporins
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
GB1572993A (en) * 1976-02-16 1980-08-13 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
IT1210868B (it) * 1982-04-01 1989-09-29 Opos Biochimica Srl Derivati della cefuroxima attivi per via orale procedimenti per laloro preparazione e relative composizioni farmaceutuche.
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process

Also Published As

Publication number Publication date
IL73989A (en) 1988-10-31
DE3500090C2 (nl) 1993-09-23
JPH0791305B2 (ja) 1995-10-04
FI83082B (fi) 1991-02-15
FI850012L (fi) 1985-07-04
PT79787B (en) 1986-12-11
CH666274A5 (de) 1988-07-15
FR2557571B1 (fr) 1987-04-17
SE8500011L (sv) 1985-07-04
ES8705891A1 (es) 1987-05-16
PH22630A (en) 1988-10-28
IT8449383A0 (it) 1984-12-31
NO850010L (no) 1985-07-04
ES8703884A1 (es) 1987-03-01
AU3704684A (en) 1985-07-11
ZA8545B (en) 1986-09-24
IT8449383A1 (it) 1986-07-01
KR850005446A (ko) 1985-08-26
SE8500011D0 (sv) 1985-01-02
GB2152504B (en) 1987-10-07
CA1265512A (en) 1990-02-06
NZ210725A (en) 1988-02-12
JPS60172989A (ja) 1985-09-06
DE3500090A1 (de) 1985-07-11
FI83082C (fi) 1991-05-27
FI850012A0 (fi) 1985-01-02
IL73989A0 (en) 1985-04-30
ES552577A0 (es) 1987-05-16
HU193076B (en) 1987-08-28
BE901436A (fr) 1985-07-03
ES539311A0 (es) 1987-03-01
LU85719A1 (fr) 1985-10-22
PT79787A (en) 1985-02-01
ATA1285A (de) 1990-08-15
IT1178349B (it) 1987-09-09
NO165400B (no) 1990-10-29
DK1585D0 (da) 1985-01-02
HK105890A (en) 1990-12-21
AT392279B (de) 1991-02-25
AU578441B2 (en) 1988-10-27
GR850007B (nl) 1985-05-03
GB8400024D0 (en) 1984-02-08
US4602012A (en) 1986-07-22
KR920001770B1 (ko) 1992-03-02
FR2557571A1 (fr) 1985-07-05
NL8403974A (nl) 1985-08-01
GB2152504A (en) 1985-08-07
HUT37800A (en) 1986-02-28
DK1585A (da) 1985-07-04
GB8500091D0 (en) 1985-02-13
NO165400C (no) 1991-02-06
SG81390G (en) 1990-11-23

Similar Documents

Publication Publication Date Title
SU1303029A3 (ru) Способ получени производных цефалоспорина
KR870000848B1 (ko) 세팔로스포린 유도체의 제조방법
SE466451B (sv) Estrar av (6r,7r)-3-karbomoyloximetyl-7-/ (z)-2-(fur-2-yl)-2-metoxi-iminoacetamido /cef-3-em-4-karboxylsyra
SE461913B (sv) Nya beta-laktamasinhibitor-foereningar vilka aer mellanprodukter vid frammstaellning av antibiotiskt verksamma beta-laktamasfoereningar
FI65623C (fi) Foerfarande foer framstaellning av antibiotiskt aktiv (6r 7r)-3-karbamoyloximetyl-7-(2-(fur-2-yl)-2-metoxiiminoacetamido)-cef-3-em-4-karboxylsyra samt dennas icke-giftiga salter
DK149062B (da) Analogifremgangsmaade til fremstilling af cefuroximestere
EP0186187B1 (en) Cephalosporin derivatives
DK161082B (da) Analogifremgangsmaade til fremstilling af syn-isomere oximderivater af 7-aminothiazolylacetamidocephalosporansyre
NL8400229A (nl) Gesubstitueerde vinyl-cefalosporinen; werkwijze voor het bereiden daarvan; farmaceutische preparaten.
CA1340672C (en) Cephalosporin derivatives
SU1250173A3 (ru) Способ получени производных цефалоспорина
DE2460537C2 (de) 7-β-Acylamido-3-em-4-carbonsäure-Antibiotika
DK147513B (da) Analogifremgangsmaade til fremstilling af cefuroximestere
Kamachi et al. Synthesis and biological activity of a new cephalosporin, BMY-28232 and its prodrug-type esters for oral use
KR100257130B1 (ko) 신규 세팔로스포린계 항생제 및 이의 제조방법
EP0723965A1 (en) Novel cephalosporin derivative
FR2583757A1 (fr) Acides propenylaminothiazolylcephalosporaniques 3-substitues et leurs esters
EP0088488B1 (en) Antibacterial agents, their preparation and use
JPS58103392A (ja) ３位においてチオメチルヘテロ環基により置換されたセフアロスポリンの新規な誘導体、これら化合物の製造方法およびこれらを含有する薬学的組成物
FR2465739A1 (fr) Cephalosporines, leurs procedes de preparation et compositions pharmaceutiques en contenant
CA1222507A (en) .beta.-LACTAM ANTIBIOTICS, PROCESSES FOR THEIR PREPARATION AND AGENTS WHICH CONTAIN THESE COMPOUNDS
US4179502A (en) 7[2-Hydroxyiminoacetamido]cephalosporins
EP0186586B1 (en) Cephem compounds and the production thereof
EP0188781B1 (en) 1-oxa-1-dethia-cephalosporin compounds and antibacterial agent comprising the same
EP0098615B1 (en) 1-oxadethiacephalosporin compound and antibacterial agent containing the same

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8500011-5

Effective date: 19930810